Spark Therapeutics (ONCE) Misses Q3 EPS by 22c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Wall St rises as Anthropic's IPO filing sharpens focus on AI trade
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
Tweet
Share
E-mailGet Alerts ONCE Hot Sheet
Join SI Premium – FREE
Spark Therapeutics (NASDAQ: ONCE) reported Q3 EPS of ($0.70), $0.22 worse than the analyst estimate of ($0.48). Revenue for the quarter came in at $1.3 million versus the consensus estimate of $4.43 million.
For earnings history and earnings-related data on Spark Therapeutics (ONCE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 1st Source (SRCE) PT Raised to $92 at KBW After a 'High Quality Result'
- Eli Lilly (LLY) PT Raised to $1,450 at Bernstein SocGen on 'International Upside Potential'
- JetBlue shares drop on creditor restructuring news amid bankruptcy filing fears
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
